Lasokun

Medicinal product

(Invented) name

Lasokun

Active substance (s)

Ranolazinas

Strength

375 mg

Pharmaceutical form

pailginto atpalaidavimo tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C01EB18, Ranolazine

Marketing authorisation holder

Zentiva k.s., Čekija

Date of authorisation

2025-02-07

Date of renewal

Documents

5693-95_pakuotes lapelis_2025-02-07.docx

5693-5694-5695_Lasokun.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

DE/H/7219/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Ranolazinas	375 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
116541	102640	1102640	lizdinė plokštelė	N30		Receptinis	LT/1/25/5693/001	Netiekiama	-	-	No	-	-
116542	102641	1102641	lizdinė plokštelė	N60		Receptinis	LT/1/25/5693/002	Netiekiama	-	-	No	-	-
116543	102642	1102642	lizdinė plokštelė	N100		Receptinis	LT/1/25/5693/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-02-07	Registruotas